ArticleNPJ precision oncology2026

Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer.

Daisuke Nishizaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.